2000年から2015年のアフリカにおける子供の成長障害の地図作成
Aaron Osgood-Zimmerman1, Anoushka I Millear1, Rebecca W Stubbs1
1Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington 98121, USA.
Nature
|March 2, 2018
まとめ
発育不全や体重不足など,アフリカでは改善がみられたが,地域差は依然として大きい. 現在の進展は2030年の栄養不良の目標を達成できない可能性があり,標的を絞った介入の必要性を強調しています.
科学分野:
- 世界保健
- 小児の栄養
- 公衆衛生の流行病学
背景:
- 子供の成長障害 (遅滞,衰弱,体重不足) は,不良な健康結果と死亡率と関連しています.
- 2000年から2015年の間にアフリカのほとんどの国で 子どもの成長の改善が観察されました
- アフリカでは子供の成長傾向とレベルが 地域的に大きく異なっています
研究 の 目的:
- アフリカ全土の子供の成長障害の傾向における地方の異質性を分析する.
- 2025年の母親,乳児,幼児の栄養目標と2030年の栄養不良に対する持続可能な開発目標に向けた進展を予測する.
- 公共衛生の介入における地理空間評価の有用性を強調する.
主な方法:
- 地域レベルでの子供の成長障害 (発育不全,減量,体重不足) を推定するために地理空間モデルを使用した.
- 2000年から2015年の動向を分析した.
- 現在の改善率に基づいて予測される将来の進展
主要な成果:
- アフリカの多くの地域は2025年の栄養目標に向けた進展を示しているが,サヘル地域では,成長の失敗率が高く続く可能性が高い.
- 現在のペースでは,この大陸は2030年の持続可能な開発目標の栄養失調を撲滅する目標を達成できなくなります.
- 成長障害のレベルと傾向の有意な地方差異が特定されました.
結論:
- 地理空間的推定は,基線を確立し,標的を絞った公衆衛生介入の指針を定める上で極めて重要です.
- 進歩を加速するには 格差をなくし 貧困層に焦点を当てる必要があります
- 2030年までに大陸と世界の栄養失調の削減目標を達成するために,緊急に,調整された戦略が必要である.
関連する概念動画
00:57Population Growth
28.7K
Population size is dynamic, increasing with birth rates and immigration, and decreasing with death rates and emigration. In ideal conditions with unlimited resources, populations can increase exponentially, which plots as a J-shaped growth rate curve of population size against time. This type of curve is characteristic of newly-introduced invasive species, or populations that have suffered catastrophic declines and are rebounding.
28.7K
01:17Pathophysiology of Heart Failure
4.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
01:27Heart Failure I: Introduction
958
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
958
01:29Heart Failure II: Pathophysiology
1.0K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
01:21Acute Respiratory Failure-I
1.1K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.1K
01:21Acute Respiratory Failure-II
1.2K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.2K